Mutation O
of O
the O
consensus B
AP I
- I
1 I
/ I
CRE I
site I
within O
ZII B
abolished O
the O
inducibility O
of O
Zp B
by O
HHV O
- O
6 O
, O
whereas O
positioning O
of O
the O
ZII B
domain I
upstream O
of O
the O
beta B
- I
globin I
minimal I
promoter I
conferred O
responsiveness O
following O
HHV O
- O
6 O
infection O
. O

Glycoprotein B
( I
GP I
) I
IX I
is O
a O
subunit O
of O
the O
von B
Willebrand I
receptor I
, O
GPIb B
- I
V I
- I
IX I
, O
which O
mediates O
adhesion O
of O
platelets O
to O
the O
subendothelium O
of O
damaged O
blood O
vessels O
. O

OBF B
- I
1 I
, O
a O
novel B
B I
cell I
- I
specific I
coactivator I
that O
stimulates O
immunoglobulin B
promoter I
activity O
through O
association O
with O
octamer B
- I
binding I
proteins I
. O

In O
summary O
, O
CD40 B
signaling O
preferentially O
induces O
SAPK B
but O
not O
MAPK B
. O

We O
found O
a O
wide O
range O
of O
TCR B
affinities O
among O
the O
different O
clonotypes O
that O
segregated O
with O
Vbeta O
usage O
. O

Finally O
, O
we O
show O
by O
both O
footprint O
analysis O
and O
functional O
assays O
that O
the O
ability O
of O
the O
G B
+ I
C I
- I
rich I
region I
to O
increase O
alpha B
- I
globin I
promoter I
activity O
from O
a O
stably O
integrated O
alpha B
- I
globin I
gene I
is O
mediated O
by O
its O
multiple B
binding I
sites I
for O
the O
transcription B
factor I
Sp1 B
. O

GIG10 B
is O
a O
novel O
sequence O
and O
GIG18 B
is O
the O
mouse O
homologue O
of O
a O
human B
expressed I
sequence I
tag I
isolated O
from O
activated O
B O
lymphocytes O
. O

In O
the O
absence O
of O
TCR B
- O
mediated O
activation O
, O
Vpr B
induces O
apoptosis O
whereas O
in O
its O
presence O
, O
Vpr B
interrupts O
the O
expected O
induction O
of O
apoptosis O
. O

Erythropoietin B
( O
Epo B
) O
, O
the O
primary O
regulator O
of O
the O
production O
of O
erythroid O
cells O
, O
acts O
by O
binding O
to O
a O
cell B
surface I
receptor I
( O
EpoR B
) O
on O
erythroid O
progenitors O
. O

Another O
limitation O
is O
that O
antioxidant O
concentrations O
high O
enough O
to O
block O
NK B
- I
kappa I
B I
activation O
were O
shown O
to O
have O
a O
suppressive O
effect O
on O
immune O
functions O
in O
vitro O
, O
because O
NAC O
and O
BHA O
blocked O
IL O
- O
2 O
- O
induced O
PBMC O
proliferation O
. O

This O
raises O
the O
intriguing O
possibility O
that O
physical O
association O
of O
the O
HsN3 B
proteasome I
subunit I
with O
HTLV B
- I
I I
Tax I
coupled O
with O
the O
independent O
interaction O
of O
Tax B
with O
either O
p100 O
or O
p65 O
- O
I B
kappa I
B I
alpha I
targets O
these O
cytoplasmic B
NF I
- I
kappa I
B I
/ I
Rel I
complexes I
to O
the O
proteasome B
for O
processing O
. O

In O
vitro O
transcription O
analysis O
using O
protein O
fractions O
enriched O
for O
the O
octamer O
- O
binding O
protein O
OTF B
- I
2 I
demonstrate O
a O
positive O
functional O
role O
for O
OTF B
- I
2 I
in O
DRA B
gene I
transcription O
. O

Retinoid B
- I
like I
receptors I
play O
a O
central O
role O
in O
hormonal O
responses O
by O
forming O
heterodimers B
with O
other O
nuclear B
hormone I
receptors I
. O

RNA B
was O
extracted O
by O
phenol O
/ O
chloroform O
and O
c B
- I
fos I
expression O
was O
analyzed O
by O
PCR O
assisted O
mRNA O
assay O
. O

A O
closely O
related O
( O
if O
not O
identical O
) O
protein O
is O
found O
in O
both O
a O
human O
megakaryocytic O
cell O
line O
and O
purified O
human O
megakaryocytes O
; O
it O
binds O
to O
promoter B
regions I
of O
two O
megakaryocytic B
- I
specific I
genes I
. O

Ligation O
of O
CD3 B
also O
induces O
the O
tyrosine O
phosphorylation O
of O
HS1 B
, O
a O
75 B
- I
kDa I
hematopoietic I
cell I
- I
specific I
intracellular I
signaling I
protein I
of O
unknown O
function O
. O

